IL-4 and TNF-α Polymorphisms Are Associated with Risk of Multiple Superficial Tumors or Carcinoma in situ Development

about

IL-4 and TNF-α Polymorphisms Are Associated with Risk of Multiple Superficial Tumors or Carcinoma in situ Development

Item

http://www.wikidata.org/entity/Q58835463

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2011

@uk

name

IL-4 and TNF-α Polymorphisms A ...... Carcinoma in situ Development

@en

IL-4 and TNF-α Polymorphisms A ...... Carcinoma in situ Development

@nl

type

Item

label

IL-4 and TNF-α Polymorphisms A ...... Carcinoma in situ Development

@en

IL-4 and TNF-α Polymorphisms A ...... Carcinoma in situ Development

@nl

prefLabel

IL-4 and TNF-α Polymorphisms A ...... Carcinoma in situ Development

@en

IL-4 and TNF-α Polymorphisms A ...... Carcinoma in situ Development

@nl

P1476

IL-4 and TNF-α polymorphisms a ...... carcinoma in situ development

@en

P2093

António Morais

http://www.w3.org/2001/XMLSchema#string

Carlos Lopes

http://www.w3.org/2001/XMLSchema#string

Joana Silva

http://www.w3.org/2001/XMLSchema#string

Lúcio Santos

http://www.w3.org/2001/XMLSchema#string

Teresina Amaro

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer: back to Virchow?

XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.

Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder.

Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications.

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation

Humoral immunity, inflammation and cancer.

P304

457-463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000331882

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rui Medeiros

P Videira

Luís Lima

P577

2011-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22104567

http://www.w3.org/2001/XMLSchema#string

P921

TNF